XPG Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of XPG Antibodies for advanced research in the field of DNA repair and cellular response to damage. XPG Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). XPG, or excision repair cross-complementing rodent repair deficiency, plays a crucial role in the nucleotide excision repair pathway, which is essential for removing bulky DNA adducts and maintaining genomic stability. XPG function is vital for preventing mutations that can lead to cancer and other genetic disorders. Research focusing on XPG has revealed significant insights into DNA repair mechanisms and potential therapeutic strategies. Scientists worldwide utilize XPG monoclonal antibodies to explore cellular responses to DNA damage and investigate repair pathways. Ongoing studies of XPG continue to uncover new aspects of genome maintenance and stability. Understanding XPG mechanisms helps identify novel therapeutic approaches for DNA damage-related diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing innovative therapeutic solutions in DNA repair research.